Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

    View: 954

    Website https://cancerimmunology.conferenceseries.com/ | Want to Edit it Edit Freely

    Category Tumor Immunology Conference, Cancer Immunology Conference, Immunotherapy Conference, Immunology conference

    Deadline: July 15, 2018 | Date: September 17, 2018-September 18, 2018

    Venue/Country: San Diego, USA, U.S.A

    Updated: 2017-09-19 21:14:50 (GMT+9)

    Call For Papers - CFP

    With the enormous response from the previous annual Tumor & Cancer Immunology conference 2017, ConferenceSeries Ltd invites all the participants from all over the world to attend 3rd International Conference on Tumor & Cancer Immunology-2018” during September 17-18, 2018 in San Diego, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The Tumor & Cancer Immunology Conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology.

    Target Audience

    Tumor & Cancer research Students, Scientists

    Tumor & Cancer Researchers

    Tumor & Cancer research Faculty

    Oncologist

    Medical Colleges

    Tumor or Cancer research Associations and Societies

    Business Entrepreneurs

    Training Institutes

    Manufacturing Medical Devices Companies


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.